[Comparative studies of various clinical and psychopharmacological parameters of schizoaffective psychosis and paranoid schizophrenia].
Two groups of male patients were investigated: 19 subjects with diagnosis of paranoid schizophrenia and 13 with schizoaffective psychosis (8 with both depressive and paranoid symptoms, 5 with manic and paranoid). All patients were treated with perazine in this same manner. During the consecutive stages of therapy the following parameters were examined and compared: clinical symptoms, DBH activity, plasma prolactin concentration and the simple reaction time task to auditory and visual stimuli. The noticeable changes, similarities and differences were described.
Masiak
M
M
Katedry i Kliniki Psychiatrii AM w Lublinie.
Perzyński
J
J
Nagay
J
J
Marmurowska-Michałowska
H
H
Olajossy
M
M
Wysocka
A
A
D000328:Adult; D003937:Diagnosis, Differential; D004299:Dopamine beta-Hydroxylase / Q000097:blood; D004334:Drug Administration Schedule; D006801:Humans; D008297:Male; D010464:Perazine / Q000008:administration & dosage*; D011388:Prolactin / Q000097:blood; D011618:Psychotic Disorders / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy; D012563:Schizophrenia, Paranoid / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy
D010464:Perazine; D011388:Prolactin; D004299:Dopamine beta-Hydroxylase
Badania porównawcze niektórych parametrów klinicznych i psychofarmakologicznych psychozy schizoafektwnej i schizofrenii paranoidalnej.